Medical and Pharmaceutical Guardant Health gets oncology innovation accolade at Healthcare Asia Medtech Awards 2026 The company was recognized for its multi-cancer detection test Rowan Dunne8 hours ago
AI and Autonomy Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI The companies plan to build proof-of-concept models that predict how patients will respond to treatment Joseph Morton4 days ago
Medical and Pharmaceutical Enliven Therapeutics stock climbs on upgrades, sector validation from Merck acquisition Enliven Therapeutics is a clinical-stage biotech company focused on developing targeted cancer drugs Joseph Morton5 days ago
Medical and Pharmaceutical Eli Lilly funds Indigenous lung health education initiative in North America 'Healthy Workforce, Productive Community' will extend for 3 years Rowan DunneMarch 25, 2026
Medical and Pharmaceutical bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction Shares rose by 73% during the session with no immediate catalyst Rowan DunneMarch 23, 2026
Medical and Pharmaceutical Guardant Health launches multi-cancer blood test in Asia through Manulife partnership Cancer remains a leading cause of death across Asia, driving demand for early screening tools Joseph MortonMarch 18, 2026
Medical and Pharmaceutical Monash University’s medical engineering institute progresses silicosis breath test Its MedTech Commercialisation Advancement Program has been expediting the tool's development Rowan DunneMarch 9, 2026
Medical and Pharmaceutical Tango Therapeutics rallies after oncology drug collaboration with Erasca Researchers think combining both drugs could create stronger and longer-lasting tumor responses Joseph MortonMarch 5, 2026
Medical and Pharmaceutical Optellum breaks new ground with TGA approval for AI-powered lung nodule solution 'Radiological computer-assisted diagnostic software for lesions suspicious of cancer' is what the FDA calls it Rowan DunneMarch 5, 2026
Medical and Pharmaceutical Kairos Pharma acquires lung cancer drug assets from Celyn Therapeutics Shares surged by 16% after the deal was announced Rowan DunneMarch 2, 2026